상세정보
Export to Refworks부가기능
Precision Medicine in Atrial Fibrillation: A Risk Model for Management with Dabigatran v. Warfarin
상세 프로파일
| 자료유형 | 학위논문 |
|---|---|
| 서명/저자사항 | Precision Medicine in Atrial Fibrillation: A Risk Model for Management with Dabigatran v. Warfarin. |
| 개인저자 | Ader, Jeremy. |
| 단체저자명 | Yale University. Yale School of Medicine. |
| 발행사항 | [S.l.]: Yale University., 2018. |
| 발행사항 | Ann Arbor: ProQuest Dissertations & Theses, 2018. |
| 형태사항 | 75 p. |
| 기본자료 저록 | Dissertation Abstracts International 79-11B(E). Dissertation Abstract International |
| ISBN | 9780438132801 |
| 학위논문주기 | Thesis (M.D.)--Yale University, 2018. |
| 일반주기 |
Source: Dissertation Abstracts International, Volume: 79-11(E), Section: B.
Adviser: Nihar R. Desai. |
| 요약 | The Precision Medicine Initiative aims to advance Medicine from "one-size-fits-all" treatments to more individualized approaches. Clinical trials evaluate treatments by analyzing average outcomes, and thus risk overlooking potential differences |
| 요약 | We analyzed the Randomized Evaluation of Long-Term Anticoagulation Therapy (RELY) trial of dabigatran versus warfarin in patients with atrial fibrillation, to determine if the application of multivariate predictive models could demonstrate heter |
| 요약 | These findings demonstrate heterogeneity of treatment effect in the RE-LY trial, and the ability of multivariate risk models to identify distinct treatment risks for individual patients. Such models could be used in clinical practice provide pat |
| 일반주제명 | Medicine. Epidemiology. |
| 언어 | 영어 |
| 바로가기 | 
: 이 자료의 원문은 한국교육학술정보원에서 제공합니다. |
